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ABSTRACT
Background: Optimal risk adjustment is a requisite precon-
dition for monitoring quality of care and interpreting public
reports of hospital outcomes. Current risk-adjustment mea-
sures have been criticized for including baseline variables that
are difficult to obtain and inadequately adjusting for high-
risk patients. The authors sought to develop highly predictive
risk-adjustment models for 30-day mortality and morbidity
based only on a small number of preoperative baseline char-
acteristics. They included the Current Procedural Terminol-
ogy code corresponding to the patient’s primary procedure
(American Medical Association), American Society of Anes-
thesiologists Physical Status, and age (for mortality) or hos-
pitalization (inpatient vs. outpatient, for morbidity).
Methods: Data from 635,265 noncardiac surgical patients
participating in the American College of Surgeons National
Surgical Quality Improvement Program between 2005 and
2008 were analyzed. The authors developed a novel algo-
rithm to aggregate sparsely represented Current Procedural
Terminology codes into logical groups and estimated uni-
variable Procedural Severity Scores—one for mortality and
morbidity, respectively—for each aggregated group. These
scores were then used as predictors in developing respective
risk quantification models. Models were validated with c-sta-
tistics, and calibration was assessed using observed-to-ex-
pected ratios of event frequencies for clinically relevant strata
of risk.
Results: The risk quantification models demonstrated ex-
cellent predictive accuracy for 30-day postoperative mortal-
ity (c-statistic [95% CI] 0.915 [0.906–0.924]) and morbid-
ity (0.867 [0.858–0.876]). Even in high-risk patients,
observed rates calibrated well with estimated probabilities for
mortality (observed-to-expected ratio: 0.93 [0.81–1.06])
and morbidity (0.99 [0.93–1.05]).
Conclusion: The authors developed simple risk-adjust-
ment models, each based on three easily obtained vari-
ables, that allow for objective quality-of-care monitoring
among hospitals.
H ETEROGENEITY among providers (i.e., cliniciansor hospitals) in the quality of health care delivered
remains an issue of mounting concern in the United States.1
A key issue in improving overall quality of the healthcare
system is identifying this heterogeneity by studying out-
comes-based performance measures. But valid outcome-
based quality monitoring efforts must properly account for
inherent variability in risk associated with differences in base-
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What We Already Know about This Topic
• Current perioperative risk-adjustment measures have been
criticized for including baseline variables that are difficult to
obtain and inadequately adjusting for high-risk patients
What This Article Tells Us That Is New
• Novel, highly predictive risk quantification models for 30-day
mortality and composite major morbidity were successfully
developed that use only three readily available patient and
procedural characteristics
 Supplemental digital content is available for this article. Direct
URL citations appear in the printed text and are available in
both the HTML and PDF versions of this article. Links to the
digital files are provided in the HTML text of this article on the
Journal’s Web site (www.anesthesiology.org).
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line characteristics among patients as well as differences in
procedural complexity.2,3
The American Society of Anesthesiologists (ASA) Physi-
cal Status Classification System has become a routine
method of preoperative risk assessment. Although the ASA
Physical Status is a baseline risk assessment and thus opera-
tive risk is not included in the score, it has been associated
with perioperative morbidity and mortality. 4–7 Combined
with other baseline factors, it may contribute to an accurate
characterization of patient risk.
Currently available outcomes-based measures may not
adequately adjust for risk, especially in sicker patients.8 To
the extent that available indices inadequately account for risk
in sicker patients, they encourage clinicians and health sys-
tems that must publically report outcomes to “cherry pick”
relatively healthy patients.9
Other scores have been developed for specific risks or for
specific patient populations, such as the Goldman Cardiac Risk
Index for cardiac risk in noncardiac surgery patients and the
European System for Cardiac Operative Risk Evaluation for
estimating operative mortality in patients undergoing cardiac
surgery.10,11 These scores, although well-established and imple-
mented, were not developed for the purpose of risk-adjusted
quality-of-care comparisons among providers with respect to
noncardiac surgical patients. More importantly, they require
information that usually is not available in administrative data-
bases that most broadly represent the U.S. surgical population.
Recently, Sessler et al. introduced a novel Risk Stratifica-
tion Index based on Medicare Provider Analysis and Review
files.12 This index improves greatly on previous models. The
Medicare Provider Analysis and Review database contains
information from claims for services and relies completely on
administrative data, namely International Classification of
Disease codes. In contrast, the procedure coding of the
American College of Surgeons National Surgical Quality Im-
provement Program (ACS-NSQIP) and several other ad-
ministrative databases uses the Healthcare Common Proce-
dure Coding System, of which the American Medical
Association Current Procedural Terminology (CPT) codes
are an integral part.13
The ACS-NSQIP, a national, prospectively implemented
program for comparative assessment and enhancement of
surgical outcomes among multiple institutions for several
surgical subspecialties, incorporates risk-adjustment indices
for 30-day mortality and 30-day morbidity.14,15 Although
these models are highly predictive, they require collection of
detailed information on a multitudinous array of patient risk
factors (including laboratory values). Generalizable and prac-
tical risk-adjustment models would best rely on a limited
number of risk factors that are routinely available for most
patients. Thus, our goal was to develop practical, highly pre-
dictive risk-adjustment models for 30-day mortality and
morbidity in the U.S. noncardiac surgical population based
only on baseline patient characteristics and CPT codes.
Materials and Methods
Data Collection
The ACS-NSQIP is a prospective, outcomes-based regis-
try for comparative assessment and enhancement of the
quality of surgical care among multiple institutions for
several surgical subspecialties.16,17 More than 250 aca-
demic and large community surgical institutions across
the United States participate in the ACS-NSQIP. Participating
institutions employ full-time surgical clinical reviewers to ensure
the integrity of perioperative and 30-day outcomes data. Fur-
thermore, routine audits are performed to monitor the accuracy
of the data collection process. Data pertaining to patients un-
dergoing certain low-morbidity, high-volume procedures are
limited to avoid overwhelming the registry. Patients included in
the ACS-NSQIP registry are enrolled in site-specific, 8-day cy-
cles to avoid systematic bias introduced by weekly patterns in
case loads.18 We used perioperative data on 635,265 noncardiac
surgery patients treated between 2005 and 2008 at participating
ACS-NSQIP surgical centers.
We withheld a randomly selected validation cohort of
50,000 patients to study the predictive accuracy and calibra-
tion of our risk models. The remaining patients’ data were
used for developing our risk models as described below. Al-
though our validation cohort was not external to the set of
ACS-NSQIP–participating hospitals, we thought the cohort
was adequate to study whether we overfit our model to the
training cohort.
The primary outcomes for our study were 30-day postop-
erative mortality and 30-day postoperative major morbidity,
which was defined as an occurrence of one or more of the
following postoperative complications: organ space infec-
tion, pneumonia, unplanned intubation, pulmonary embo-
lism, ventilator dependence more than 48 h, acute renal fail-
ure, stroke/cerebral vascular accident with neurologic deficit,
coma more than 24 h, cardiac arrest requiring cardiopulmo-
nary resuscitation, myocardial infarction, transfusion of 5 or
more units erythrocytes within 72 h, sepsis/septic shock, and
mortality.
Statistical Analysis
SAS statistical software version 9.2 (SAS Institute, Cary,
NC) was used for data management, whereas statistical mod-
eling was performed using R software version 2.8.1 (The R
Foundation for Statistical Computing, Vienna, Austria) and,
specifically, its Design and Hmisc packages.19
Our overall modeling approach was implemented in two
phases. First, for each of our two outcomes (mortality and
morbidity) we developed a univariable score measuring pro-
cedure-associated risks (hereafter referred to as Procedural
Severity Scores or PSS). Second, we developed multivariable
logistic regression models for mortality and morbidity, each
using the respective PSS and routinely available patient char-
acteristics as predictor variables.
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Univariable Risk Scores Associated with the Primary
Procedure
Development of the univariable procedure-associated risk
scores was as follows: The ACS-NSQIP database includes
procedural data, encoded using the CPT codes.20 Our main
predictor variable was based on the primary CPT code asso-
ciated with each patient’s visit. Frequencies of individual
(primary) CPT codes in the training data set varied widely,
ranging from 1 patient (369 CPT codes) to 39,373 patients
(laparoscopic cholecystectomy); among the 2,555 CPT
codes present in the training data set, 1,721 codes were rep-
resented by 30 or fewer patients.
Aggregation of Procedures
The Clinical Classifications Software for Services and Proce-
dures (CCS, U.S. Department of Health and Human Ser-
vices Agency for Healthcare Research and Quality) aggre-
gates each individual CPT code into 1 of 244 mutually
exclusive, clinically appropriate categories. Based on these
CCS procedure groups, we postulated that the aggregation of
many sparsely represented CPT codes would provide in-
creased precision for predicting the primary outcomes of our
study. Furthermore, we considered the possibility that even
some CCS procedure groups might have similarly low fre-
quencies of cases. On the other hand, certain CPT codes
(such as laparoscopic cholecystectomy) were sufficiently
common not to require aggregation.
We therefore aggregated procedures represented by fewer
than a certain number of patients—which we denote by
N*—into the associated CCS procedure group. Further-
more, we allowed for the possibility that even after this ag-
gregation, certain CCS procedure groups would be sparsely
represented. These sparsely represented CCS procedure
groups were further aggregated into an all-purpose “other”
group using the same rule (aggregate if the number of pa-
tients is less than N*). For 30-day mortality and composite
30-day morbidity separately, we selected N* objectively such
that the aggregation routine yielded maximal predictive ac-
curacy among the training cohort.
Determination of Minimum CCS Procedure Group Size
for Aggregation
We implemented a cross-validation study (for each outcome)
as follows: For candidate values of N* ranging between 10
and 5,000, we randomly partitioned the training cohort into
10 subgroups of equal size. Then, for each subgroup, we used
the other 90% of the data to (1) aggregate procedures using
the methodology outlined above (with the candidate N* in
question); (2) estimate the incidence of the outcome within
each (aggregated) group; and (3) evaluate the predictive ac-
curacy of these incidences for the reserved 10% of the data
using the c-statistic (the c-statistic is a quantity ranging be-
tween 0.5 and 1.0, for which 0.5 represents no discriminative
ability beyond random guessing, whereas 1.0 represents per-
fect prediction19). This process was repeated over the 10
randomly partitioned subgroups, and the c-statistics were
averaged to obtain an estimate of the expected c-statistic
associated with the candidate N* in question. Smoothing
spline regression was then used to find N* (i.e., the value that
maximized the cross-validated c-statistic), as shown in figure
1 for 30-day mortality.
Postaggregation Assignment of PSS
Once N* was selected using the cross-validation routine
described in the previous section (again, specific to each
outcome), the incidence of the outcome for each aggre-
gated group was estimated using the entire training co-
hort. Then the PSS (our measure of univariable procedure
risk) was defined for 30-day mortality as the twelfth root
of these estimated incidences (which we refer to as PSS-
mortality). Because these incidence estimates were heavily
skewed to the right (i.e., most procedures are associated
with low risk of the outcome, but a few procedures are
associated with a larger risk), this twelfth-root transforma-
tion was warranted to model a linear relationship between
PSS mortality and log-odds of mortality. With methodol-
ogy akin to that used to obtain our PSS mortality score, we
defined PSS morbidity using the cube-root transforma-
tion of the aggregated group-specific incidence observed
among the training cohort.
Multivariable Modeling with PSS and Other Patient
Characteristics
With the PSS now defined, we proceeded to build our overall
risk models combining procedural and patient characteristics
as follows: First, multivariable logistic regression was used
with PSS and all baseline risk factors showing potential pre-
dictive ability as determined by relatively large values of test
statistics for univariable association with the outcome (e.g.,
univariable chi-square test statistic greater than 1,000 for
Fig. 1. Choice of N* for mortality: Cross-validation was used
to estimate the expected c-statistic for new data over mini-
mum group sizes ranging from 10 to 5,000 (only sample sizes
from 30 to 150 are shown). N*  77 was chosen because it
maximized the smooth regression relationship between
cross-validated c-statistic and log-sample size.
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categorical predictors). In this “full” model, the relationship
between PSS and the log-odds of the outcome was modeled
linearly, whereas restricted cubic splines with four equally
spaced knots were used for all other continuous risk factors to
allow for potential nonlinearities in the estimated relation-
ships. C-statistics for this model (and their associated 95%
CI, estimated using normal approximation theory for pro-
portions), applied to both the training and validation data
sets, were then estimated. As mentioned, the utility of such a
full model suffers from difficulties associated with collecting
data on many baseline risk factors. Thus, we considered a
“reduced” model, which incorporated a limited number of
selected risk factors with the goal of minimizing the reduc-
tion in the model c-statistics.
Validation of Fitted Models
Our definition of the composite morbidity outcome differs
slightly from that which was used to define the morbidity
index currently available in the ACS-NSQIP database (for
instance, we include mortality as one of the individual out-
comes comprising composite morbidity, whereas the ACS-
NSQIP morbidity index does not). Furthermore, the mor-
bidity and mortality indices in the ACS-NSQIP database are
estimated for only general and vascular surgery patients, and
these indices supplement baseline and procedural risk factors
with preoperative laboratory results. Nonetheless, we com-
pared c-statistics arising from our models to those from the
ACS-NSQIP indices for general and vascular surgery
patients.
Calibration (the agreement between the predicted
probabilities from a model and the observed outcome pro-
portions) was assessed for our final models for mortality
and morbidity within our validation cohort. First, we di-
vided the validation cohort patients into groups based on
their predicted probabilities of the outcome; then, we es-
timated group-specific ratios of observed-to-expected out-
come counts (O/E ratios), using a Poisson log-linear
model. Groups were selected to reflect clinically meaning-
ful strata of risk. The expected outcome count within each
group was the sum of the predicted probabilities of its
members. A global Wald test of all O/E ratios equal to 1
was performed with a significance criterion of 0.05, and
Bonferroni-adjusted 95% simultaneous CIs were esti-
mated for each O/E ratio.
Results
Aggregation of Procedures
The optimal minimum group-specific sample size for the
aggregation of procedures into groups was N*  77 for mor-
tality (fig. 1) and N*  23 for morbidity. The resulting
estimates of PSS mortality and PSS morbidity, as well as
details about the aggregation of individual CPT codes into
CCS procedure groups and of CCS procedure groups into an
all-purpose other category, are given in Supplemental Digital
Content 1, http://links.lww.com/ALN/A738, for each indi-
vidual CPT code.
Discrimination
In general, 30-day mortality was more accurately predicted
than composite 30-day morbidity, as evidenced by the higher
c-statistics among the randomly determined subset of 50,000
validation cases (table 1).
For mortality, PSS predicted the outcome better than
did individual CPT codes (c-statistic [95% CI] 0.867
[0.859 – 0.876] vs. 0.847 [0.838 – 0.856]). Our reduced
model for mortality included the following risk factors:
PSS-mortality, ASA Physical Status, and age. This model
resulted in a validation data c-statistic of 0.915 (0.906 –
0.924), whereas the ACS-NSQIP mortality score of Khuri
et al., as applied to our validation cohort, gave a c-statistic of
0.941 (0.931–0.950).14
Predictive ability for PSS-morbidity was essentially simi-
lar to that observed for CPT codes (table 1). For this out-
come, our reduced model incorporated PSS-morbidity, ASA
Physical Status, and hospitalization (i.e., inpatient vs. outpa-
tient); this model produced a validation data c-statistic of
0.867 (0.858–0.876). No appreciable increase in predictive
accuracy was observed when using the comparator ACS-
NSQIP morbidity score of Daley et al. (C  0.875 [0.866–
0.884]), whose analysis incorporated more risk factors and
was based on a subset of the noncardiac surgical population
(whereas our models were developed and validated using all
patients in the registry).15
Before incorporation of patient risk factors, the proce-
dural information alone predicted both outcomes quite
accurately. The PSS developed for 30-day mortality re-
sulted in a univariable c-statistic (95% CI 0.867 [0.859 –
0.876]; table 1), whereas the PSS developed for the com-
posite morbidity outcome was 0.839 (0.830 – 0.848);
these c-statistics were comparable or slightly higher (more
discriminative) than the c-statistics achieved by using the
individual CPT codes.
Combining patient demographic and morphometric
information with the PSS increased the c-statistic for both
outcomes. In the full model for 30-day mortality (which
incorporated 24 total predictors), the c-statistic was 0.936
(0.927– 0.945), which was comparable with the predictive
ability achieved by the ACS-NSQIP mortality score of
Khuri et al. (as applied to our validation cohort).14 Our
reduced model for 30-day mortality (which included only
PSS-mortality, ASA Physical Status, and age) predicted
the outcome only marginally less accurately than did the
models that incorporated many predictors. Similar results
were obtained for the composite 30-day postoperative
morbidity/mortality outcome; although overall this out-
come was predicted less accurately than 30-day mortality,
our reduced model performed as accurately as the full
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model and as accurately as the ACS-NSQIP morbidity
score of Daley et al.15
Calibration
Calibration of the two final models is summarized in table
2; the P value of the global Wald calibration test was 0.64
for 30-day mortality and 0.40 for 30-day morbidity,
meaning that we did not find sufficient evidence indicat-
ing lack of agreement between model predictions and the
observed outcomes. Specifically, the ratio of observed/
expected number of deaths among patients with more
than 10% predicted probability based on our reduced
model for mortality (i.e., high-risk patients) was 0.93
(0.81–1.06). Likewise, the ratio of observed/expected number of





30-day mortality Univariable model (CPT code) 0.847 (0.838–0.856)
Univariable model (PSS mortality) 0.867 (0.859–0.876)
Full model* 0.936 (0.927–0.945)
Reduced model for 30-day mortality† 0.915 (0.906–0.924)
NSQIP probability of mortality‡ 0.941 (0.931–0.950)
30-day composite major morbidity Univariable model (CPT code) 0.836 (0.827–0.845)
Univariable model (PSS morbidity) 0.839 (0.830–0.848)
Full model§ 0.876 (0.867–0.885)
Reduced model for 30-day morbidity 0.867 (0.858–0.876)
NSQIP probability of morbidity‡ 0.875 (0.866–0.884)
* Includes the following preoperative variables as predictors: PSS mortality, age, body mass index (truncated at 75), American Society
of Anesthesiologists (ASA) Physical Status, emergent status, functional health status, preoperative sepsis/systemic inflammatory
response syndrome, ventilator dependence, impaired sensorium, dyspnea, transfer status (admitted directly from home vs. admitted
from other facility), ascites, current pneumonia, renal failure, bleeding disorders, open wound/wound infection, currently on dialysis,
hospitalization status (inpatient vs. outpatient), history of chronic obstructive pulmonary disease, disseminated cancer, weight loss
(more than 10% of body weight in prior 6 months), steroid use for chronic condition, rest pain/gangrene, and diabetes mellitus.
† Includes PSS mortality, ASA Physical Status, and age as predictors. ‡ These models incorporate all baseline risk factors (including
laboratory measurements) and procedural data. § Includes the following preoperative variables as predictors: PSS morbidity, age, body
mass index (truncated at 75), ASA Physical Status, emergent status, functional health status, preoperative sepsis/systemic inflamma-
tory response syndrome, ventilator dependence, impaired sensorium, dyspnea, transfer status (admitted directly from home vs.
admitted from other facility), ascites, current pneumonia, renal failure, bleeding disorders, open wound/wound infection, hospitalization
status (inpatient vs. outpatient), history of chronic obstructive pulmonary disease, and transfusion (more than 4 units erythrocytes within
72 h of start of surgery).  Includes PSS morbidity, ASA Physical Status, and hospitalization as predictors.
CPT  Current Procedural Terminology; NSQIP  National Surgical Quality Improvement Program; PSS  procedural severity score.












30-day mortality 0.5% 32,832 (66.0%) 41 (5%) 37 (5%) 1.12 (0.74–1.69)
0.6–1.0% 4,352 (8.7%) 32 (4%) 31 (4%) 1.02 (0.64–1.63)
1.1–2.0% 4,195 (8.4%) 58 (7%) 61 (7%) 0.96 (0.68–1.36)
2.1–5.0% 4,486 (9.0%) 150 (19%) 142 (18%) 1.05 (0.85–1.31)
5.0–10.0% 1,996 (4.0%) 149 (19%) 137 (17%) 1.09 (0.88–1.35)
10.0% 1,891 (3.8%) 370 (46%) 399 (49%) 0.93 (0.81–1.06)
30-day major morbidity 1.0% or lower 15,653 (31.4%) 50 (1%) 67 (2%) 0.75 (0.51–1.08)
1.1–2.0% 6,376 (12.8%) 90 (2%) 95 (3%) 0.94 (0.72–1.25)
2.1–5.0% 9,927 (19.9%) 333 (9%) 322 (9%) 1.03 (0.89–1.20)
5.0–10.0% 6,827 (13.7%) 500 (13%) 493 (13%) 1.01 (0.90–1.14)
10.1–20.0% 5,745 (11.5%) 873 (23%) 847 (23%) 1.03 (0.94–1.13)
20.0% 5,245 (10.5%) 1,874 (50%) 1,898 (51%) 0.99 (0.93–1.05)
Calibration is the relationship between observed and expected outcome counts as a function of the predicted probability of outcome.
* The expected number of events is the sum of the predicted probability of the event among all patients within a stratum. † Estimated
using a Poisson log-linear model (incorporating the expected number of events as an offset variable).
O/E  observed-to-expected.
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patients experiencing composite major morbidity among pa-
tients with more than 20% predicted probability based on our
reduced model for morbidity was 0.99 (0.93–1.05).
Obtaining Risk Estimates
Nomograms (graphic tools for obtaining regression model
estimates) are provided for our reduced models (along
with instructions) in figures 2 and 3. Within these nomo-
grams, the axis length corresponding to each risk factor
represents the relative degree of contribution of that risk
factor in the model; thus, PSS mortality and PSS morbid-
ity were the strongest predictors among those chosen for
their respective models. ASA Physical Status, the next
strongest predictor in each of the reduced models, dis-
played a relatively larger influence on the prediction for
morbidity than it did for mortality.
Fig. 3. Nomogram for predicting 30-day major morbidity based on Current Procedural Terminology (CPT) code, American
Society of Anesthesiologists (ASA) Physical Status, and hospitalization. Instructions: Find the Procedural Severity Score for
morbidity (PSS morbidity) in Supplemental Digital Content 1 for the patient’s primary CPT code. Locate this score on the axis
labeled “PSS-Morbidity” by interpolating between the displayed values, and draw a vertical line to the “Points” axis to find the
points toward 30-day morbidity associated with the patient’s procedure. Repeat this process for ASA Physical Status and
hospitalization and add the three resulting point values to obtain the patient’s total points. Locate this number on the “Total
Points” axis (shaded region) and draw a vertical line to the axis labeled “Predicted Probability of 30-Day Major Morbidity or
Mortality (%).” This value represents the prediction for the patient.
Fig. 2. Nomogram for predicting 30-day mortality based on Current Procedural Terminology (CPT) code, American Society of
Anesthesiologists (ASA) Physical Status, and age. Instructions: Find the Procedural Severity Score for mortality (PSS mortality) in
Supplemental Digital Content 1 for the patient’s primary CPT code. Locate this score on the axis labeled “PSS-Mortality” by
interpolating between the displayed values, and draw a vertical line up to the “Points” axis to find the points toward 30-day mortality
associated with the patient’s procedure. Repeat this process for age and ASA Physical Status and add the three resulting point values
to obtain the patient’s total points. Locate this number on the “Total Points” axis (shaded region) and then draw a vertical line to the
axis labeled “Predicted Probability of 30-Day Mortality (%).” This value represents the prediction for the patient.
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We have developed an R package that contains functions
for obtaining predictions for an entire data set; it is available
on our Web site.**
Discussion
The models previously established for risk adjustment within
the ACS-NSQIP database proved to be highly discrimina-
tive; consequently, the expected risk for participating general
and vascular surgery patients is well-defined. Quality-of-care
investigations that compare observed outcome rates to (mod-
el-based) expected rates among ACS-NSQIP providers ap-
pear to adequately account for differences in risk profiles of
individual patient populations. However, external imple-
mentation of these models is severely hampered by their de-
pendence on a multitude of patient and procedural risk fac-
tors, including many that are not generally available for each
patient (such as preoperative laboratory measurements like
serum creatinine). Our reduced models for 30-day mortality
and morbidity each required only three pieces of data to
obtain an estimate of risk and achieved excellent predictive
accuracy for 30-day postoperative mortality (c-statistic 0.915
[0.906–0.924]) and morbidity (0.867 [0.858–0.876]).
This level of discrimination was only marginally lower than
the far-more-complicated ACS-NSQIP mortality14 and
morbidity15 scores. Even in high-risk patients, observed rates
calibrated well with estimated probabilities for mortality
(O/E ratio: 0.93 [0.81–1.06]) and morbidity (0.99 [0.93–
1.05]).
Quality improvement initiatives face several hurdles in
clinical practice. Lack of confidence among physicians and
hospitals in the validity of existing outcomes-based quality
measures can impede successful clinical quality improve-
ment.21 Specifically, there is a perception that currently
available outcomes-based measures underrepresent risk asso-
ciated with high-risk patients. In our models, the observed
mortality rate among high-risk patients (as defined by more
than 10% predicted probability of mortality) was between
19% less and 6% greater than that expected by our model,
with 95% confidence. Similar results were observed for com-
posite morbidity; using more than 20% predicted probabil-
ity to characterize high-risk patients for this outcome, the
observed morbidity rates were not more than 7% different
from that expected by our model.
Our models suggest that ASA Physical Status, in conjunc-
tion with other variables, provides an accurate depiction of
risk. Although ASA Physical Status previously has been
shown to measure risk accurately, its implementation in
quality-of-care monitoring has been limited. This is because
of a perceived lack of availability and an ongoing concern
that the scoring is subjective in nature.22–24 Although ASA
Physical Status is not universally available in administra-
tive datasets, it is a powerful parameter that condenses
relevant clinical measures of patient risk and acuity into a
single variable.
The integration of clinical parameters with administrative
variables allows for the greatest opportunity to predict base-
line risk in surgical patients. Each source, clinical or admin-
istrative, has its benefits and disadvantages. The ACS-
NSQIP data set as a clinical registry is highly regarded for its
data quality. Critics often point out a lack of detail for intra-
operative or anesthesia-related variables, but outcome defini-
tions are highly detailed, universally applied, and rigorously
audited. Using data from clinical registries such as the ACS-
NSQIP brings a certain limitation compared with purely
administrative data (mainly based on International Classifi-
cation of Diseases, Ninth Revision codes) but also offers
unique advantages, such as temporal relations. As Orkin
states in a recent editorial, clinical data sets can be rich in
detail but may lack uniform definitions and miss substantial
amounts of data.25 Because administrative data are fre-
quently used for billing purposes, data sets are more complete
and uniform. However, diagnostic and procedure codes tend
to lack specificity to encode complex clinical scenarios and
fail to distinguish temporal relationships.25 We believe one
of the strengths of the presented model is achieving an accu-
rate prediction of outcomes with the combined use of clinical
and administrative data while using only the most relevant
data points.
In addition to use in studies evaluating relative quality of
care among providers and health systems, these models may
be used to provide specific risk assessments to individual
patients. However, we note that physicians should not use
our estimates as a basis for decisions between or among pro-
cedures in a given patient because our estimates do not rep-
resent the (immeasurable) differential risk for individuals
among procedures. Instead, they represent the expected risk
among large groups of patients with similar characteristics
undergoing a given procedure. Patients undergoing a specific
procedure will be more homogeneous than a global popula-
tion of surgical patients. Applying broadly defined quality
improvement models to narrowly defined populations likely
will result in reduced discriminative ability. Thus, specific
risk quantification models for a given disease should be used,
when they exist, for predicting individual outcomes. Such
models have been developed, for example, for colon resec-
tions, esophagectomies in resectable esophageal cancer, and
gastric bypass surgery.26–28
We used data on 585,265 patients available from the
ACS-NSQIP database at the time of analysis to build our
models. It is possible that incremental improvements in pre-
dictive accuracy may be achieved by including data from
future years because more predictions specific to individual
procedures will be possible. That is, more individual proce-
dures will have enough patients to meet the minimum
bucket size for PSS estimation, instead of being statistically
grouped with other similar procedures. Furthermore, to the
extent that providers vary in quality of care, our risk quanti-
** http://www.clevelandclinic.org/rqi. Accessed February 21,
2011.
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fication models might be further improved by incorporating,
say, the treating institution, as a predictor variable.
Our models displayed a high level of predictive accuracy
on a randomly withheld validation cohort of 50,000 pa-
tients. But developing predictive models requires external
validation as well as internal validation. To the extent that
outcomes among participating hospitals differ from out-
comes among nonparticipating hospitals at a given level of
patient/surgical risk, our model may not calibrate well
among the nonparticipating institutions. An external valida-
tion with complete 30-day outcomes on all hospitals would
address this issue. However, identifying a suitable registry for
such external validation will be challenging given the quality
of the ACS-NSQIP data set and its specific definitions, out-
comes, and scope.
Public reporting of provider outcome statistics is a central
tenet of national health care quality improvement, and re-
ported results will have considerable financial impact
throughout the healthcare system. An obvious use of our
prediction models is to risk-adjust estimates of overall per-
formance indices (i.e., observed-to-expected risk ratios)
among institutions. Adjusted performance can then be com-
pared across organizations to assess and improve quality of
care.
In summary, we developed risk quantification models
for 30-day mortality and composite major morbidity us-
ing novel severity scoring methodology for each primary
CPT code. These models use just three readily available
patient and procedural characteristics without appreciably
sacrificing predictive accuracy compared with models that
require far more information, including information that
generally is not available for most patients. Furthermore,
these models remain accurate even for high-risk patients.
Thus, they can be used to establish accurately the expected
risk in various surgical populations for the purpose of
fairly comparing quality-of-care among American health-
care institutions.
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ANESTHESIOLOGY REFLECTIONS
Sir Humphry Davy, Bart., from Lady Davy
In December of 1820, Lady Davy commissioned the new President of the Royal Academy (P.R.A.),
Sir Thomas Lawrence, to paint a portrait of her husband, Sir Humphry Davy, to celebrate his election
as President of the Royal Society (P.R.S.). At one third that original’s size, the smaller oil (left) was
curatorially donated to the Wood Library-Museum in honor of Colin Davy Bause and Evan Blake
Bause. The close up (right) reads “Sir Humphry Davy, Bart., from Lady Davy.” Months after Davy
posed for Lawrence, the two men would meet again. Representing the sciences and the arts,
Davy, P.R.S., and Lawrence, P.R.A., would reunite in July of 1821 to walk down the coronation
aisle together for the crowning of King George IV. (Copyright © the American Society of Anes-
thesiologists, Inc. This image also appears in the Anesthesiology Reflections online collection
available at www.anesthesiology.org.)
George S. Bause, M.D., M.P.H., Honorary Curator, ASA’s Wood Library-Museum of Anesthesi-
ology, Park Ridge, Illinois, and Clinical Associate Professor, Case Western Reserve University,
Cleveland, Ohio. UJYC@aol.com.
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